$49.99
Research Studies:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
AOD-9604 5mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
AOD-9604 5mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 221231-10-3 |
|---|---|
| Molecular Formula | C78H123N23O23S2 |
| Molecular Weight | 1815.08 g/mol |
| Purity | ≥99% |
| Sequence | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe |
| Synthesis Method | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Water/Sterile Diluent |
| Stability & Storage | Up to 24 months at -20°C. Avoid repeated freeze-thaw cycles. |
| Applications | Fat loss, muscle regeneration, metabolic disorders research |
| Appearance | White to off-white powder |
| Regulatory/Compliance | Not for human consumption. For research use only. |
| Safety Information | MSDS available upon request |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy AOD-9604 online should evaluate AOD-9604 as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, AOD-9604 purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate AOD-9604 for controlled research procurement through Pure Lab Peptides, with emphasis on AOD-9604 supplier documentation, analytical testing, and research-use-only boundaries.
Researchers can buy AOD-9604 online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase `buy AOD-9604 online` is addressed here as laboratory research procurement intent, not personal-use intent. In this context, “buy” means that qualified researchers, laboratory buyers, research institutions, and technical procurement teams are comparing research-use-only suppliers, documentation practices, product form, lot traceability, and analytical records.
A compliant procurement review does not ask how a compound is used by people. It asks whether AOD-9604 research-use-only labeling is clear, whether the supplier avoids therapeutic positioning, whether the AOD-9604 COA is batch-specific, whether the lot number can be matched across records, and whether analytical methods support identity and purity documentation.
For an AOD-9604 research material, commercial search intent should be converted into a documentation workflow: confirm intended use, review the certificate of analysis, compare lot identifiers, evaluate identity testing, record storage guidance, and assess supplier transparency. This keeps online sourcing tied to controlled laboratory procurement rather than consumer-style purchasing.
AOD-9604 is identified in chemical databases as a peptide compound associated with the molecular formula C78H123N23O23S2 and PubChem CID 71300630 [1]. NCATS Inxight Drugs lists AOD-9604 under the preferred name LAT-8881, with FDA UNII 7UP768IP4M and CAS 221231-10-3, and provides a systematic peptide sequence description that includes a cyclic disulfide bridge [2].
DrugBank describes AOD9604 as a synthetic analogue associated with a human growth hormone-derived domain in historical drug-development records [3]. In laboratory procurement language, that background should be treated as compound-identification context, not as a product claim. AOD-9604 is best presented here as a peptide research compound requiring identity documentation, purity review, lot-level traceability, and controlled handling records.
Analytical literature has also discussed AOD9604 in detection and in vitro metabolism research, including a Drug Testing and Analysis paper describing the peptide as a C-terminal fragment of human growth hormone residues 177-191 with an added tyrosine residue at the N-terminus [4]. Separate analytical work has described identification and characterization of AOD9604 in unknown peptide preparations, showing why compound identity cannot be inferred from labeling alone [5].
Because AOD-9604 falls into a metabolic-pathway research category, product language must remain conservative. Metabolic pathway literature should not be translated into weight-loss, performance, or wellness claims for RUO materials.
Researchers search “buy AOD-9604 online” to evaluate whether an RUO supplier can support laboratory procurement with adequate documentation. The search is not a request for personal guidance. It is a request to compare AOD-9604 research material availability, RUO labeling, COA access, stated purity, analytical methods, product form, storage guidance, and supplier documentation.
A qualified buyer may also search buy AOD-9604 to identify whether a supplier makes batch-specific records available before procurement. For Pure Lab Peptides, the expected evaluation points include ≥99% purity positioning, lyophilized powder form, batch-specific COA availability, and consistency between the product page, product label, lot number, and certificate of analysis.
Good procurement practice separates commercial convenience from scientific documentation. A supplier may offer online ordering infrastructure, but the laboratory review still depends on identity testing, purity documentation, analytical traceability, and recordkeeping. FDA analytical-method guidance emphasizes documentation of identity, quality, purity, and related attributes in regulated analytical contexts, which reflects the broader importance of method-supported documentation in laboratory decision-making [6].
Researchers who buy AOD-9604 online for laboratory research should evaluate quality signals before treating any supplier page as procurement-ready. HPLC is widely used in peptide analysis and purification, and peptide-focused HPLC literature describes multiple separation modes relevant to peptide characterization [7]. Mass spectrometry is also suited to synthetic peptide identity and purity assessment when interpreted with appropriate analytical context [8].
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the available batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
AOD-9604 purity documentation should be reviewed together with compound identity, method information, and lot traceability. A complete procurement file should include the compound name, product name, lot number, test date, purity percentage, testing method, identity confirmation, molecular weight or sequence information where relevant, chromatogram or mass data when provided, product form, and storage documentation.
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. LC-HRMS literature on peptide drugs and related impurities supports the role of liquid chromatography and high-resolution mass spectrometry in qualitative and quantitative peptide-drug characterization [9]. Additional LC-HRMS work on structurally related peptide impurities shows why impurity and identity review may require method-specific interpretation rather than reliance on a single percentage value [10].
Method validation frameworks are also relevant to documentation review. FDA’s Q2(R2) guidance page states that validation of analytical procedures provides a general framework for analytical validation principles [11]. ISO/IEC 17025 describes competence, impartiality, and consistent operation requirements for testing and calibration laboratories, which are useful concepts when research teams evaluate third-party testing documentation [12].
Laboratory recordkeeping should also preserve the basis for procurement decisions. In FDA GLP regulations for nonclinical laboratory studies, test and control article characterization includes documenting identity, strength, purity, composition, and batch information [13]. The same regulation requires systems for proper storage, contamination control, identification, and receipt/distribution documentation for test and control articles [14]. Those regulatory provisions are not a claim about AOD-9604 approval or use; they are cited as documentation principles for laboratory article control.
Published literature on AOD-9604 includes database records, analytical detection studies, preclinical metabolic-pathway papers, and clinical safety/tolerability summaries. This literature helps define the research context, but it should not be converted into product-use guidance for research-use-only materials.
Early AOD9604 literature includes studies of a synthetic human growth hormone-derived domain in preclinical metabolic models [15]. Another preclinical paper examined human growth hormone and AOD9604 in relation to lipid-metabolism pathways and beta(3)-adrenergic receptor research models [16]. These papers are useful for understanding how the compound appears in scientific literature, not for making claims about RUO products.
Analytical and testing literature has also examined AOD-9604. One paper concluded that AOD-9604 did not influence the WADA hGH isoform immunoassay, placing the compound within a specialized analytical-testing context rather than a product-benefit context [17]. A separate investigational-drug review described the historical development status of AOD-9604 in 2004 [18].
Published clinical literature should not be interpreted as use guidance for RUO materials. Clinical safety and metabolism publications on AOD9604 exist outside the scope of this product-procurement article [19] [20]. Review literature has also summarized AOD9604 in broader investigational pharmacology discussions, but that context does not establish therapeutic, diagnostic, wellness, or procurement claims for any research-use-only material [21].
The evidence landscape for AOD-9604 should be read by category. Database records support identification, analytical papers support testing context, preclinical papers support literature mapping, and supplier COAs support lot-level procurement review. None of these categories replaces RUO labeling or batch-specific documentation.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, or classification [1] [2] | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | Relevant metabolic-pathway and model-specific research areas [15] [16] | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification [7] [8] | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations [22] [23] | Laboratory documentation | Supports research workflow planning |
For AOD-9604, the central compliance issue is the difference between scientific context and product positioning. Research teams may discuss database identity, analytical methods, and published literature categories. They should not turn metabolic-pathway literature into product claims.
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “AOD-9604 is discussed in published research related to metabolic-pathway research.” | Describes literature context without making a product claim | “AOD-9604 helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy AOD-9604 for results.” |
| “Pure Lab Peptides supplies AOD-9604 as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies AOD-9604 for therapy.” |
| “The phrase buy AOD-9604 online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy AOD-9604 online for personal use.” |
| “AOD-9604 supplier documentation should include lot-level traceability.” | Supports research records and procurement review | “Supplier claims can replace analytical documentation.” |
Pure Lab Peptides presents AOD-9604 5mg as a research-use-only material. The product is positioned with a ≥99% purity claim, lyophilized powder form, available batch-specific COA documentation, product page documentation, storage and handling information, lot-level traceability, and supplier transparency. Researchers should review the product page and batch-specific documentation as part of their procurement file.
Review the Pure Lab Peptides AOD-9604 research-use-only product details for RUO labeling, product details, purity information, and batch-specific documentation. Researchers comparing broader laboratory materials can also review the Pure Lab Peptides research peptide collection for category-level procurement context.
Because AOD-9604 is supplied as a lyophilized powder, storage and handling documentation should be captured in laboratory records. Peptide stability literature describes degradation pathways and formulation considerations for peptides, reinforcing why storage documentation matters for research material integrity [22]. Reviews on peptide physical stability further describe intrinsic and external factors that can influence peptide stability [23].
Buy AOD-9604 online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Published literature about AOD-9604 may help researchers map compound history, analytical detection, and research-category context. It does not establish instructions, claims, or expected outcomes for an AOD-9604 research-use-only product. Published research context should remain separate from supplier claims.
A stated purity percentage is only one part of procurement review. AOD-9604 identity testing, lot number consistency, testing method, chromatographic or mass data, and batch-specific COA documentation should be evaluated together. This is especially important for peptide research materials where related impurities or misidentification can affect research records.
AOD-9604 COA review should be batch-specific. A generic quality statement does not provide the same recordkeeping value as a certificate tied to a specific lot. Laboratory buyers should match the compound name, lot number, product form, testing date, and method details across the label and documentation.
Research-use-only labeling does not support human use, animal use, clinical use, diagnostic use, therapeutic use, or veterinary use. It narrows the procurement context to controlled laboratory research. For AOD-9604, RUO positioning should be reinforced by supplier language that avoids dosing, administration, and personal-use claims.
Supplier descriptions are not substitutes for analytical records. Researchers should prioritize AOD-9604 supplier documentation that includes available batch-specific COA information, purity documentation, identity testing, lot-level traceability, product form, and storage guidance. Claims without documentation should not drive procurement decisions.
Researchers can buy AOD-9604 online for laboratory research from an RUO supplier that provides clear research-use-only labeling, available batch-specific COA documentation, purity information, identity documentation, storage guidance, and lot-level traceability. Pure Lab Peptides provides an AOD-9604 5mg product page for researchers reviewing product details and documentation.
Before buying AOD-9604 online, researchers should check RUO labeling, product name consistency, lot number matching, AOD-9604 COA availability, purity documentation, identity testing method, lyophilized powder form, storage information, and supplier language. The supplier should avoid human-use, animal-use, therapeutic, diagnostic, dosing, or administration claims.
A COA matters when buying AOD-9604 because it supports batch-specific documentation. Researchers should review the compound name, lot number, testing method, purity percentage, identity information, and any chromatogram or mass data provided. AOD-9604 purity documentation should be evaluated with identity and lot traceability, not as a standalone number.
AOD-9604 discussed here is not intended for human or animal consumption. This article addresses AOD-9604 research-use-only procurement for qualified laboratory settings. It does not provide clinical guidance, veterinary guidance, personal-use guidance, dosing information, administration instructions, therapeutic claims, or wellness claims.
Research use only means AOD-9604 is positioned as a laboratory research material, not as a consumer, clinical, diagnostic, or veterinary product. For procurement teams, RUO review includes documentation, labeling, COA availability, identity testing, purity data, storage information, and supplier transparency. FDA’s RUO guidance for IVD products also illustrates how intended-use language and labeling must remain aligned in laboratory contexts [24].
Published literature about AOD-9604 should be interpreted as scientific context, not product-use guidance. Database records, analytical studies, preclinical research, and clinical publications can help researchers understand compound identity and literature history. They do not authorize or support human-use, animal-use, therapeutic, diagnostic, wellness, or personal-use claims for RUO materials.
Qualified researchers evaluating AOD-9604 should review product labeling, COA status, identity documentation, storage information, and supplier transparency before selecting any research-use-only material. Review the AOD-9604 product page for RUO labeling, purity information, and available batch-specific documentation.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.